STAU1 and amyotrophic lateral sclerosis: Silencing STAU1 was able to prevent UPR activation, including a strong decrease in CHOP, indicating STAU1 contributed to the pathological phenotype in cells established from ALS and FTD patients (Fig. 5a,b).